RGEN · Company research
Repligen Corp (RGEN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance UK | Repligen Corporation (RGEN) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance | Repligen Corporation (RGEN) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 17, 2026 | neutral | 0 | 0.6 |
| Repligen Corp (RGEN) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 85/100 - GuruFocus | Repligen Corp (RGEN) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 85/100 GuruFocus | View source ↗ | GuruFocus | Oct 16, 2026 | neutral | 0 | 0.6 |
| Repligen: A Buy As Its Growth Engine Gears Up (NASDAQ:RGEN) - Seeking Alpha | Repligen: A Buy As Its Growth Engine Gears Up (NASDAQ:RGEN) Seeking Alpha | View source ↗ | Seeking Alpha | Oct 15, 2026 | neutral | 0 | 0.6 |
| Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada | Repligen Corporation (RGEN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 14, 2026 | neutral | 0 | 0.6 |
| Repligen (NasdaqGS:RGEN) Stock Forecast & Analyst Predictions - Simply Wall Street | Repligen (NasdaqGS:RGEN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 14, 2026 | neutral | 0 | 0.6 |
| Weekly Recap: BioLife cash-and-stock deal and Q3 2026 outlook details - TradingView | Weekly Recap: BioLife cash-and-stock deal and Q3 2026 outlook details TradingView | View source ↗ | TradingView | Oct 12, 2026 | neutral | 0 | 0.6 |
| Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance | Repligen Corporation (RGEN) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| A 700-share stock grant joins options with a $174.86 exercise price for Repligen (RGEN)’s chief product officer. - Stock Titan | A 700-share stock grant joins options with a $174.86 exercise price for Repligen (RGEN)’s chief product officer. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| One holder reports no voting power in Repligen (RGEN), despite a 7.36M-share passive stake. - Stock Titan | One holder reports no voting power in Repligen (RGEN), despite a 7.36M-share passive stake. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| 18 commercially approved therapies are supported by BioLife's cell-preserving media. Repligen completed the deal. - Stock Titan | 18 commercially approved therapies are supported by BioLife's cell-preserving media. Repligen completed the deal. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| Repligen (RGEN) Stock Looks Stretched After A 32% One Year Run - Simply Wall Street | Repligen (RGEN) Stock Looks Stretched After A 32% One Year Run Simply Wall Street | View source ↗ | Simply Wall Street | Oct 1, 2026 | neutral | 0 | 0.6 |
| Continuous Bioprocessing Technologies Market - Global Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR | The global continuous bioprocessing technologies market is projected to grow from USD 4.8 billion in 2026 to USD 8.5 billion by 2031, driven by rising biologics demand, regulatory support, and the biopharmaceutical industry's shift from batch to continuous production. Key growth drivers include cost efficiency, improved quality, and faster time to market, though high capital investment and technical complexity remain challenges. | View source ↗ | GlobeNewswire Inc. | Oct 1, 2026 | bullish | 1 | 1 |
| Continuous Bioprocessing Technologies Market - Global Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR | The global continuous bioprocessing technologies market is projected to grow from USD 4.8 billion in 2026 to USD 8.5 billion by 2031, driven by rising biologics demand, regulatory support, and the biopharmaceutical industry's shift from batch to continuous production. Key growth drivers include cost efficiency, improved quality, and faster time to market, though high capital investment and technical complexity remain challenges. | View source ↗ | GlobeNewswire Inc. | Oct 1, 2026 | bullish | 1 | 1 |
| Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? - TradingView | Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? TradingView | View source ↗ | TradingView | Sep 28, 2026 | neutral | 0 | 0.6 |
| Repligen (RGEN) Stock Looks Near Fair Value After Recent Rebound - Yahoo Finance | Repligen (RGEN) Stock Looks Near Fair Value After Recent Rebound Yahoo Finance | View source ↗ | Yahoo Finance | Sep 3, 2026 | neutral | 0 | 0.6 |
| Repligen (RGEN) Stock Could Be 1% Overvalued Despite Its 45% Run - Yahoo Finance | Repligen (RGEN) Stock Could Be 1% Overvalued Despite Its 45% Run Yahoo Finance | View source ↗ | Yahoo Finance | Aug 20, 2026 | neutral | 0 | 0.6 |
| Why Repligen (RGEN) Stock Is Up Today - Yahoo Finance | Why Repligen (RGEN) Stock Is Up Today Yahoo Finance | View source ↗ | Yahoo Finance | Jul 29, 2026 | neutral | 0 | 0.6 |
| Why Repligen (RGEN) Stock Is Up Today - StockStory | Why Repligen (RGEN) Stock Is Up Today StockStory | View source ↗ | StockStory | Jul 28, 2026 | neutral | 0 | 0.6 |
| Why Repligen (RGEN) Stock Is Down Today - Quiver Quantitative | Why Repligen (RGEN) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 21, 2026 | neutral | 0 | 0.6 |
| Why Repligen (RGEN) Stock Is Trading Lower Today - Yahoo Finance | Why Repligen (RGEN) Stock Is Trading Lower Today Yahoo Finance | View source ↗ | Yahoo Finance | Jul 21, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.